Chung-Sung Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Chung-Sung Lee has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Hee Sook Hwang
Department of Pharmaceutical Engineering, Dankook University, Cheonan 31116, Republic of Korea
10 shared publications - Min Lee
Division of Oral and Systemic Health Sciences, School of Dentistry, University of California, Los Angeles, CA 90095, USA
5 shared publications Geun Jin Song
Department of Medical Science, Soonchunhyang University, Asan 31538, Republic of Korea
3 shared publicationsJae Hwan Lee
Department of Medical Science, Soonchunhyang University, Asan 31538, Republic of Korea
3 shared publications- Chae Yeong Lee
Department of Pharmaceutical Engineering, Dankook University, Cheonan 31116, Republic of Korea
2 shared publications Chen Chen
Division of Advanced Prosthodontics, University of California, Los Angeles, California 90095, United States
2 shared publications
Latest Publications
- Open Access
Organic–Inorganic Hyaluronic Acid/Sumecton Nanocomposite Hydrogels for Osteogenic Applications
While their biocompatibility and extracellular matrix-mimetic properties make hyaluronic acid (HA)-based hydrogels attractive biomaterials for bone regenerative applications, their limited mechanical stability and insufficient osteogenic activity restrict broader utility. Here, we present an organic–inorganic nanocomposite hydrogel integrating catechol-functionalized HA with Sumecton clay (SU) nanosheets as multifunctional inorganic junction domains. Oxidative crosslinking of dopamine-functionalized HA established the primary hydrogel network, while the resulting hybrid network exhibited injectability and structural recovery following deformation. Incorporation of 2% SU increased the compressive modulus from approximately 4.6 to 6.0 kPa and delayed hydrogel degradation, while only modestly affecting equilibrium water content. The hybrid hydrogels also exhibited antimicrobial and catechol-mediated antioxidant activities, establishing a multifunctional microenvironment suited to tissue regeneration. SU-containing hydrogels promoted the osteogenic differentiation of encapsulated stem cells, as evidenced by increased alkaline phosphatase activity and matrix mineralization. SAG was incorporated into SU with a loading efficiency of approximately 95%, and SU@SAG-containing hydrogels further enhanced osteogenic differentiation and mineralization. Gene expression analysis showed increased expression of Hedgehog-associated markers together with modulation of Wnt/β-catenin-related genes, suggesting signaling responses associated with enhanced osteogenesis. Collectively, this study demonstrates an organic–inorganic network engineering strategy to develop structurally robust and biologically functional HA-based nanocomposite hydrogels for bone regenerative applications.
Open AccessOrganic–Inorganic Hyaluronic Acid/Sumecton Nanocomposite Hydrogels for Osteogenic Applications
While their biocompatibility and extracellular matrix-mimetic properties make hyaluronic acid (HA)-based hydrogels attractive biomaterials for bone regenerative applications, their limited mechanical stability and insufficient osteogenic activity restrict broader utility. Here, we present an organic–inorganic nanocomposite hydrogel integrating catechol-functionalized HA with Sumecton clay (SU) nanosheets as multifunctional inorganic junction domains. Oxidative crosslinking of dopamine-functionalized HA established the primary hydrogel network, while the resulting hybrid network exhibited injectability and structural recovery following deformation. Incorporation of 2% SU increased the compressive modulus from approximately 4.6 to 6.0 kPa and delayed hydrogel degradation, while only modestly affecting equilibrium water content. The hybrid hydrogels also exhibited antimicrobial and catechol-mediated antioxidant activities, establishing a multifunctional microenvironment suited to tissue regeneration. SU-containing hydrogels promoted the osteogenic differentiation of encapsulated stem cells, as evidenced by increased alkaline phosphatase activity and matrix mineralization. SAG was incorporated into SU with a loading efficiency of approximately 95%, and SU@SAG-containing hydrogels further enhanced osteogenic differentiation and mineralization. Gene expression analysis showed increased expression of Hedgehog-associated markers together with modulation of Wnt/β-catenin-related genes, suggesting signaling responses associated with enhanced osteogenesis. Collectively, this study demonstrates an organic–inorganic network engineering strategy to develop structurally robust and biologically functional HA-based nanocomposite hydrogels for bone regenerative applications.
- Open Access
- 20 August 2026
- Published by MDPI AG in Biomimetics
- Vol. 11  (8) , 593
Bio-Inspired Adhesive Hydrogels for Localized Therapeutic Delivery: From Catechol Chemistry to Smart Biointerfaces
Localized therapeutic delivery has gained increasing attention as an effective strategy in enhancing treatment efficacy while at the same time minimizing systemic side effects. However, conventional hydrogel-based therapeutic delivery systems often suffer from poor tissue retention and insufficient control over delivery. This drawback is highly pronounced in wet and dynamic biological environments. So, catechol-based adhesive hydrogels have emerged as promising biomaterials for localized therapeutic applications and are inspired by the remarkable wet-adhesion capability of marine mussels. As a highlight, catechol chemistry enables robust tissue adhesion through multiple intermolecular interactions, including hydrogen bonding, metal coordination, and covalent coupling. At the same time, it contributes to hydrogel cohesion and structural stability. Recent advances in hydrogel engineering have expanded the functionality of these systems through integration of injectable formulations, self-healing networks, nanocomposite reinforcement, and stimuli-responsive biointerfaces. These developments have transformed adhesive hydrogels from tissue sealants into multifunctional therapeutic platforms capable of enhancing tissue retention, regulating therapeutic release, and dynamically interacting with biological microenvironments. Here, we review molecular mechanisms underlying catechol-mediated adhesion and discuss recent progress in advanced adhesive hydrogel systems. We further highlight their therapeutic applications in wound healing, musculoskeletal regeneration, exosome and gene delivery, immunomodulatory therapies, and localized cancer therapy. Finally, current translational challenges and future opportunities in developing next-generation smart biointerfaces for precision regenerative medicine are discussed.
- 20 August 2026
- Published by MDPI AG in Biomimetics
- Vol. 11  (8) , 593
Open AccessBio-Inspired Adhesive Hydrogels for Localized Therapeutic Delivery: From Catechol Chemistry to Smart Biointerfaces
Localized therapeutic delivery has gained increasing attention as an effective strategy in enhancing treatment efficacy while at the same time minimizing systemic side effects. However, conventional hydrogel-based therapeutic delivery systems often suffer from poor tissue retention and insufficient control over delivery. This drawback is highly pronounced in wet and dynamic biological environments. So, catechol-based adhesive hydrogels have emerged as promising biomaterials for localized therapeutic applications and are inspired by the remarkable wet-adhesion capability of marine mussels. As a highlight, catechol chemistry enables robust tissue adhesion through multiple intermolecular interactions, including hydrogen bonding, metal coordination, and covalent coupling. At the same time, it contributes to hydrogel cohesion and structural stability. Recent advances in hydrogel engineering have expanded the functionality of these systems through integration of injectable formulations, self-healing networks, nanocomposite reinforcement, and stimuli-responsive biointerfaces. These developments have transformed adhesive hydrogels from tissue sealants into multifunctional therapeutic platforms capable of enhancing tissue retention, regulating therapeutic release, and dynamically interacting with biological microenvironments. Here, we review molecular mechanisms underlying catechol-mediated adhesion and discuss recent progress in advanced adhesive hydrogel systems. We further highlight their therapeutic applications in wound healing, musculoskeletal regeneration, exosome and gene delivery, immunomodulatory therapies, and localized cancer therapy. Finally, current translational challenges and future opportunities in developing next-generation smart biointerfaces for precision regenerative medicine are discussed.
- Open Access
- 28 May 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18  (6) , 668
Exosomes as Disease-Informed Nanoplatforms for Pulmonary Fibrosis: From Pathogenic Signaling to Precision Diagnosis and Therapy
Pulmonary fibrosis (PF) is a progressive and often fatal interstitial lung disease for which the currently available pharmacological therapies remain largely limited to slowing disease progression rather than reversing established fibrosis. This limitation has stimulated increasing interest in innovative therapeutic platforms capable of modulating complex fibrotic pathways. In this context, exosomes—nanoscale extracellular vesicles—have emerged as promising cell-free nanocarriers due to their intrinsic biocompatibility, low immunogenicity, and ability to be engineered for targeted drug delivery. In this review, we provide a comprehensive overview of both natural and engineered exosome-based strategies for the diagnosis and treatment of pulmonary fibrosis. We summarize recent advances in exosome engineering, including ligand functionalization, glycoengineering, and therapeutic cargo loading, highlighting how these approaches may support the development of more targeted and potentially personalized nanotherapeutic strategies. We further discuss emerging hybrid delivery platforms, such as exosome–liposome chimeras and hydrogel-based depots, which may enhance pulmonary retention, improve therapeutic durability, and enable controlled drug release. Finally, we outline key challenges and opportunities for clinical translation, including large-scale manufacturing, regulatory considerations, and clinically relevant delivery routes such as inhalation-based administration. Collectively, this review provides a translational perspective on engineered exosomes as emerging nanotherapeutic platforms for pulmonary fibrosis.
- 28 May 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18  (6) , 668
Open AccessExosomes as Disease-Informed Nanoplatforms for Pulmonary Fibrosis: From Pathogenic Signaling to Precision Diagnosis and Therapy
Pulmonary fibrosis (PF) is a progressive and often fatal interstitial lung disease for which the currently available pharmacological therapies remain largely limited to slowing disease progression rather than reversing established fibrosis. This limitation has stimulated increasing interest in innovative therapeutic platforms capable of modulating complex fibrotic pathways. In this context, exosomes—nanoscale extracellular vesicles—have emerged as promising cell-free nanocarriers due to their intrinsic biocompatibility, low immunogenicity, and ability to be engineered for targeted drug delivery. In this review, we provide a comprehensive overview of both natural and engineered exosome-based strategies for the diagnosis and treatment of pulmonary fibrosis. We summarize recent advances in exosome engineering, including ligand functionalization, glycoengineering, and therapeutic cargo loading, highlighting how these approaches may support the development of more targeted and potentially personalized nanotherapeutic strategies. We further discuss emerging hybrid delivery platforms, such as exosome–liposome chimeras and hydrogel-based depots, which may enhance pulmonary retention, improve therapeutic durability, and enable controlled drug release. Finally, we outline key challenges and opportunities for clinical translation, including large-scale manufacturing, regulatory considerations, and clinically relevant delivery routes such as inhalation-based administration. Collectively, this review provides a translational perspective on engineered exosomes as emerging nanotherapeutic platforms for pulmonary fibrosis.
- Open Access
- 1 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Biomaterials Research
- Vol. 30, 0303
Hybrid Dissolving Microneedles Incorporating Hyaluronic Acid Microdepots for Pain-free and Long-acting Corticosteroid Therapy
Inflammatory skin diseases are chronic conditions characterized by persistent inflammation and disrupted skin barriers, necessitating sustained drug delivery. This study presents a long-acting hybrid dissolving microneedle (DMN) patch incorporating hyaluronic acid (HA)-based microparticle depots (TA@MDepots) for intradermal delivery of triamcinolone acetonide (TA). HA is modified to HA acetate to enhance compatibility with hydrophobic TA, enabling efficient microdepot formulation. These TA@MDepots are integrated into the DMN tip layer using mold-casting, resulting in patches with strong mechanical properties and rapid tip dissolution (<3 min) upon application. In vitro and ex vivo studies demonstrate effective skin penetration, sustained dermal retention, and prolonged TA release. The hybrid patch shows excellent cytocompatibility and significantly reduces tumor necrosis factor-alpha and interleukin-6 levels in activated macrophages. In vivo, the patch outperforms commercial TA ointment in a murine ulcer model by accelerating wound closure, reducing epidermal thickening, and lowering inflammatory cytokine expression, despite a lower TA dosage and fewer applications. Histological analyses confirm skin structure restoration and immune modulation, while systemic toxicity assessments show no adverse effects. This hybrid DMN platform offers a minimally invasive, biocompatible, and patient-friendly strategy for prolonged corticosteroid delivery in chronic inflammatory skin diseases and represents a promising alternative to conventional topical or injectable therapies.
- 1 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Biomaterials Research
- Vol. 30, 0303
Open AccessHybrid Dissolving Microneedles Incorporating Hyaluronic Acid Microdepots for Pain-free and Long-acting Corticosteroid Therapy
Inflammatory skin diseases are chronic conditions characterized by persistent inflammation and disrupted skin barriers, necessitating sustained drug delivery. This study presents a long-acting hybrid dissolving microneedle (DMN) patch incorporating hyaluronic acid (HA)-based microparticle depots (TA@MDepots) for intradermal delivery of triamcinolone acetonide (TA). HA is modified to HA acetate to enhance compatibility with hydrophobic TA, enabling efficient microdepot formulation. These TA@MDepots are integrated into the DMN tip layer using mold-casting, resulting in patches with strong mechanical properties and rapid tip dissolution (<3 min) upon application. In vitro and ex vivo studies demonstrate effective skin penetration, sustained dermal retention, and prolonged TA release. The hybrid patch shows excellent cytocompatibility and significantly reduces tumor necrosis factor-alpha and interleukin-6 levels in activated macrophages. In vivo, the patch outperforms commercial TA ointment in a murine ulcer model by accelerating wound closure, reducing epidermal thickening, and lowering inflammatory cytokine expression, despite a lower TA dosage and fewer applications. Histological analyses confirm skin structure restoration and immune modulation, while systemic toxicity assessments show no adverse effects. This hybrid DMN platform offers a minimally invasive, biocompatible, and patient-friendly strategy for prolonged corticosteroid delivery in chronic inflammatory skin diseases and represents a promising alternative to conventional topical or injectable therapies.
- Open Access
- 6 December 2025
- Published by MDPI AG in Pharmaceutics
- Vol. 17  (12) , 1574
Stable Cholesterol–Palmitic Acid Sterosomes as Smart Nanocarriers for pH-Sensitive Doxorubicin Delivery in Breast Cancer Therapy
Background: Breast cancer remains one of the most prevalent and lethal malignancies worldwide. Although doxorubicin (DOX) is widely used as a first-line chemotherapeutic agent, its clinical utility is constrained by dose-limiting cardiotoxicity and systemic adverse effects. Nanoparticulate drug delivery systems have therefore attracted attention for improving DOX stability, biocompatibility, and tumor selectivity. In this study, we explored sterosomes—simple non-phospholipid nanocarriers composed of cholesterol and palmitic acid—as an alternative DOX delivery platform with pH-responsive properties. Methods: DOX-loaded sterosomes (DOX-STs) were prepared using cholesterol and palmitic acid to impart acid-sensitive behavior. The nanocarriers were systematically evaluated through particle characterization, physicochemical stability assessment, in vitro pH-dependent drug release, and cellular uptake studies. Furthermore, therapeutic efficacy and systemic safety were investigated in an MDA-MB-231 breast cancer xenograft mouse model. Results: DOX-STs exhibited particle sizes below 100 nm, high encapsulation efficiency, and excellent colloidal stability for 28 days. The sterosomes demonstrated accelerated DOX release under acidic conditions relative to physiological pH, consistent with their pH-responsive design. Enhanced cellular uptake was observed in both MCF-7 and MDA-MB-231 cells. In vivo, DOX-ST treatment resulted in significant tumor growth suppression and prolonged survival without notable body weight loss, indicating reduced systemic toxicity compared to free DOX. Conclusions: This study presents a simple sterosome-based nanocarrier system that achieves pH-responsive DOX release and enhanced antitumor efficacy while minimizing toxicity. These findings highlight the potential of sterosomes as a translatable nanomedicine platform for breast cancer therapy.
- 6 December 2025
- Published by MDPI AG in Pharmaceutics
- Vol. 17  (12) , 1574
Open AccessStable Cholesterol–Palmitic Acid Sterosomes as Smart Nanocarriers for pH-Sensitive Doxorubicin Delivery in Breast Cancer Therapy
Background: Breast cancer remains one of the most prevalent and lethal malignancies worldwide. Although doxorubicin (DOX) is widely used as a first-line chemotherapeutic agent, its clinical utility is constrained by dose-limiting cardiotoxicity and systemic adverse effects. Nanoparticulate drug delivery systems have therefore attracted attention for improving DOX stability, biocompatibility, and tumor selectivity. In this study, we explored sterosomes—simple non-phospholipid nanocarriers composed of cholesterol and palmitic acid—as an alternative DOX delivery platform with pH-responsive properties. Methods: DOX-loaded sterosomes (DOX-STs) were prepared using cholesterol and palmitic acid to impart acid-sensitive behavior. The nanocarriers were systematically evaluated through particle characterization, physicochemical stability assessment, in vitro pH-dependent drug release, and cellular uptake studies. Furthermore, therapeutic efficacy and systemic safety were investigated in an MDA-MB-231 breast cancer xenograft mouse model. Results: DOX-STs exhibited particle sizes below 100 nm, high encapsulation efficiency, and excellent colloidal stability for 28 days. The sterosomes demonstrated accelerated DOX release under acidic conditions relative to physiological pH, consistent with their pH-responsive design. Enhanced cellular uptake was observed in both MCF-7 and MDA-MB-231 cells. In vivo, DOX-ST treatment resulted in significant tumor growth suppression and prolonged survival without notable body weight loss, indicating reduced systemic toxicity compared to free DOX. Conclusions: This study presents a simple sterosome-based nanocarrier system that achieves pH-responsive DOX release and enhanced antitumor efficacy while minimizing toxicity. These findings highlight the potential of sterosomes as a translatable nanomedicine platform for breast cancer therapy.
- Open Access
- 21 August 2025
- Published by MDPI AG in Biomimetics
- Vol. 10  (8) , 552
Hyaluronic-Acid-Coated Sterosome for Dasatinib Delivery in Hepatocellular Carcinoma: Preparation, Physicochemical Characterization, and In Vitro Evaluation
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide, and treatment remains challenging due to high recurrence rates, resistance to chemotherapy, and severe side effects. Dasatinib (Das) has shown therapeutic potential against HCC, but its clinical use is limited by poor bioavailability and short half-life (~3–4 h). Here, we developed a hyaluronic acid (HA)-coated sterosome for targeted and sustained delivery of Das to CD44-overexpressing HCC cells. Sterosomes composed of octadecylamine and cholesterol at a 5:5 (v/v) ratio were prepared via thin-film hydration and sonication, yielding stable particles (~90 nm) with high encapsulation efficiency (EE ~72%) for uncoated vesicles and ~58% after HA coating. HA-sterosomes (HA-St-Das) exhibited a uniform size (≈200 nm) and negative surface charge (–26 mV), with improved storage stability and resistance to lyophilization. In vitro release studies demonstrated pH-responsive Das release accelerated under acidic conditions (pH 6.0–5.0), mimicking tumor and lysosomal environments. In HepG2 cells, HA-St-Das exhibited enhanced cytotoxicity (IC50 ~7.0 μM) and prolonged intracellular retention compared to free Das and uncoated carriers. Fluorescence microscopy confirmed receptor-mediated uptake via CD44, leading to gradual and sustained intracellular delivery. Overall, the HA-St-Das system provides biocompatible, targeted, and controlled Das delivery, addressing key limitations of current liver cancer therapies and representing a promising nanomedicine platform for further development.
- 21 August 2025
- Published by MDPI AG in Biomimetics
- Vol. 10  (8) , 552
Open AccessHyaluronic-Acid-Coated Sterosome for Dasatinib Delivery in Hepatocellular Carcinoma: Preparation, Physicochemical Characterization, and In Vitro Evaluation
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide, and treatment remains challenging due to high recurrence rates, resistance to chemotherapy, and severe side effects. Dasatinib (Das) has shown therapeutic potential against HCC, but its clinical use is limited by poor bioavailability and short half-life (~3–4 h). Here, we developed a hyaluronic acid (HA)-coated sterosome for targeted and sustained delivery of Das to CD44-overexpressing HCC cells. Sterosomes composed of octadecylamine and cholesterol at a 5:5 (v/v) ratio were prepared via thin-film hydration and sonication, yielding stable particles (~90 nm) with high encapsulation efficiency (EE ~72%) for uncoated vesicles and ~58% after HA coating. HA-sterosomes (HA-St-Das) exhibited a uniform size (≈200 nm) and negative surface charge (–26 mV), with improved storage stability and resistance to lyophilization. In vitro release studies demonstrated pH-responsive Das release accelerated under acidic conditions (pH 6.0–5.0), mimicking tumor and lysosomal environments. In HepG2 cells, HA-St-Das exhibited enhanced cytotoxicity (IC50 ~7.0 μM) and prolonged intracellular retention compared to free Das and uncoated carriers. Fluorescence microscopy confirmed receptor-mediated uptake via CD44, leading to gradual and sustained intracellular delivery. Overall, the HA-St-Das system provides biocompatible, targeted, and controlled Das delivery, addressing key limitations of current liver cancer therapies and representing a promising nanomedicine platform for further development.
- 6 May 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 311  (Pt 3) , 143980
Photo-curable layered double hydroxide-hyaluronic acid-composite hydrogels with multifunctional properties for growth factor-free bone regeneration
- 6 May 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 311  (Pt 3) , 143980
Photo-curable layered double hydroxide-hyaluronic acid-composite hydrogels with multifunctional properties for growth factor-free bone regeneration
- 2 May 2025
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 678, 125653
Dissolving microneedle patch integrated with microparticle depots for sustained intradermal delivery of donepezil
- 2 May 2025
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 678, 125653
Dissolving microneedle patch integrated with microparticle depots for sustained intradermal delivery of donepezil
- Open Access
Exosome-Integrated Hydrogels for Bone Tissue Engineering
Exosome-integrated hydrogels represent a promising frontier in bone tissue engineering, leveraging the unique biological properties of exosomes to enhance the regenerative capabilities of hydrogels. Exosomes, as naturally occurring extracellular vesicles, carry a diverse array of bioactive molecules that play critical roles in intercellular communication and tissue regeneration. When combined with hydrogels, these exosomes can be spatiotemporally delivered to target sites, offering a controlled and sustained release of therapeutic agents. This review aims to provide a comprehensive overview of the recent advancements in the development, engineering, and application of exosome-integrated hydrogels for bone tissue engineering, highlighting their potential to overcome current challenges in tissue regeneration. Furthermore, the review explores the mechanistic pathways by which exosomes embedded within hydrogels facilitate bone repair, encompassing the regulation of inflammatory pathways, enhancement of angiogenic processes, and induction of osteogenic differentiation. Finally, the review addresses the existing challenges, such as scalability, reproducibility, and regulatory considerations, while also suggesting future directions for research in this rapidly evolving field. Thus, we hope this review contributes to advancing the development of next-generation biomaterials that synergistically integrate exosome and hydrogel technologies, thereby enhancing the efficacy of bone tissue regeneration.
Open AccessExosome-Integrated Hydrogels for Bone Tissue Engineering
Exosome-integrated hydrogels represent a promising frontier in bone tissue engineering, leveraging the unique biological properties of exosomes to enhance the regenerative capabilities of hydrogels. Exosomes, as naturally occurring extracellular vesicles, carry a diverse array of bioactive molecules that play critical roles in intercellular communication and tissue regeneration. When combined with hydrogels, these exosomes can be spatiotemporally delivered to target sites, offering a controlled and sustained release of therapeutic agents. This review aims to provide a comprehensive overview of the recent advancements in the development, engineering, and application of exosome-integrated hydrogels for bone tissue engineering, highlighting their potential to overcome current challenges in tissue regeneration. Furthermore, the review explores the mechanistic pathways by which exosomes embedded within hydrogels facilitate bone repair, encompassing the regulation of inflammatory pathways, enhancement of angiogenic processes, and induction of osteogenic differentiation. Finally, the review addresses the existing challenges, such as scalability, reproducibility, and regulatory considerations, while also suggesting future directions for research in this rapidly evolving field. Thus, we hope this review contributes to advancing the development of next-generation biomaterials that synergistically integrate exosome and hydrogel technologies, thereby enhancing the efficacy of bone tissue regeneration.
- Open Access
Nanoclay-Composite Hydrogels for Bone Tissue Engineering
Nanoclay-composite hydrogels represent a promising avenue for advancing bone tissue engineering. Traditional hydrogels face challenges in providing mechanical strength, biocompatibility, and bioactivity necessary for successful bone regeneration. The incorporation of nanoclay into hydrogel matrices offers a potential unique solution to these challenges. This review provides a comprehensive overview of the fabrication, physico-chemical/biological performance, and applications of nanoclay-composite hydrogels in bone tissue engineering. Various fabrication techniques, including in situ polymerization, physical blending, and 3D printing, are discussed. In vitro and in vivo studies evaluating biocompatibility and bioactivity have demonstrated the potential of these hydrogels for promoting cell adhesion, proliferation, and differentiation. Their applications in bone defect repair, osteochondral tissue engineering and drug delivery are also explored. Despite their potential in bone tissue engineering, nanoclay-composite hydrogels face challenges such as optimal dispersion, scalability, biocompatibility, long-term stability, regulatory approval, and integration with emerging technologies to achieve clinical application. Future research directions need to focus on refining fabrication techniques, enhancing understanding of biological interactions, and advancing towards clinical translation and commercialization. Overall, nanoclay-composite hydrogels offer exciting opportunities for improving bone regeneration strategies.
Open AccessNanoclay-Composite Hydrogels for Bone Tissue Engineering
Nanoclay-composite hydrogels represent a promising avenue for advancing bone tissue engineering. Traditional hydrogels face challenges in providing mechanical strength, biocompatibility, and bioactivity necessary for successful bone regeneration. The incorporation of nanoclay into hydrogel matrices offers a potential unique solution to these challenges. This review provides a comprehensive overview of the fabrication, physico-chemical/biological performance, and applications of nanoclay-composite hydrogels in bone tissue engineering. Various fabrication techniques, including in situ polymerization, physical blending, and 3D printing, are discussed. In vitro and in vivo studies evaluating biocompatibility and bioactivity have demonstrated the potential of these hydrogels for promoting cell adhesion, proliferation, and differentiation. Their applications in bone defect repair, osteochondral tissue engineering and drug delivery are also explored. Despite their potential in bone tissue engineering, nanoclay-composite hydrogels face challenges such as optimal dispersion, scalability, biocompatibility, long-term stability, regulatory approval, and integration with emerging technologies to achieve clinical application. Future research directions need to focus on refining fabrication techniques, enhancing understanding of biological interactions, and advancing towards clinical translation and commercialization. Overall, nanoclay-composite hydrogels offer exciting opportunities for improving bone regeneration strategies.